Clinical trial tests mammo + 3D ultrasound in breast cancer detection

A clinical trial of U-Systems' somo•v Automated Breast Ultrasound has been initiated to determine whether 3D ultrasound can improve breast cancer detection in women with dense breasts when used in combination with mammography screening.

The European Asymptomatic Screening Study (EASY) at Capio Saint Göran Hospital, in Stockholm intends to recruit 8,000 asymptomatic women with dense breast tissue, according to Sunnyvale, Calif.-based U-Systems. The company stated its aim to incorporate its 3D ultrasound imaging technology into the more common European technique of double-reading of mammography in order to improve breast cancer detection.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.